All Stories

  1. Rapid motility arrest of the Lyme disease spirochete, Borrelia burgdorferi, by vaccine-induced OspA antibodies
  2. Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice
  3. Broadly conserved protective epitopes on the lyme disease vaccine antigen, OspA
  4. OspA antibodies inhibit the in vitro transmigration of Borrelia burgdorferi
  5. An Fc-silent OspA monoclonal antibody passively protects mice from tick and intradermal Borrelia burgdorferi challenge
  6. Maternal expression and breast milk transfer of an mRNA- encoded monoclonal antibody in a murine model of cholera
  7. A Broadly Conserved Protective Epitope on the Lyme Disease Vaccine Antigen, OspA
  8. A Chip‐Based Surveillance Platform for Detecting Antibody‐Based Immunity and Immune Escape Using SARS‐CoV‐2 Pseudovirus Surrogates
  9. OspA Antibodies Inhibit the In vitro Transmigration of Borreliellia burgdorferi
  10. Germline encoded residues dominate the interaction of a human monoclonal antibody with decorin binding protein A of Borrelia burgdorferi
  11. A Salmonella enterica serovar Typhimurium genome-wide CRISPRi screen reveals a role for type 1 fimbriae in evasion of antibody-mediated agglutination
  12. Inter-laboratory harmonization of microsphere immunoassays for SARS-CoV-2 antibody detection in contrived dried blood spots and oral fluids
  13. Maternal transfer of mRNA LNP-derived, pathogen-specific, monoclonal IgG to suckling mice
  14. A Refined Human Linear B Cell Epitope Map of Outer Surface Protein C (OspC) From the Lyme Disease Spirochete, Borrelia burgdorferi
  15. PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies
  16. ASalmonella entericaserovar Typhimurium Genome-wide CRISPRi Screen Reveals a Role for Type 1 Fimbriae in Evasion of Antibody-Mediated Agglutination
  17. Quantitating SARS-CoV-2 neutralizing antibodies from human dried blood spots
  18. A type-specific B cell epitope at the apex of Outer surface protein C (OspC) of the Lyme disease spirochete,Borreliella burgdorferi
  19. Antibody Profiles Elicited by Potent and Subpotent Whole Cell Pertussis Vaccines in Mice
  20. Inter-laboratory harmonization of microsphere immunoassays for SARS-CoV-2 antibody detection in dried blood spots and oral fluids
  21. A Biparatopic Intrabody Renders Vero Cells Impervious to Ricin Intoxication
  22. Structure of a Human Monoclonal Antibody in Complex with Outer Surface Protein C of the Lyme Disease Spirochete, Borreliella burgdorferi
  23. A Biparatopic Intrabody Renders Vero Cells Impervious to Ricin Intoxication
  24. Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges
  25. A refined human linear B cell epitope map of Outer surface protein C (OspC) from the Lyme disease spirochete,Borreliella burgdorferi
  26. Inflammatory Profiles Induced by Intranasal Immunization with Ricin Toxin-immune Complexes
  27. Structure of a human monoclonal antibody in complex with Outer surface protein C (OspC) of the Lyme disease spirochete,Borreliella burgdorferi
  28. Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA)
  29. Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood Spots
  30. Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study
  31. Single-domain antibodies reveal unique borreliacidal epitopes on the Lyme disease vaccine antigen, Outer surface protein A (OspA)
  32. Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination
  33. The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops
  34. An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions
  35. Structural Basis of Antibody-Mediated Inhibition of Ricin Toxin Attachment to Host Cells
  36. Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
  37. Inflammatory Profiles Induced following Intranasal Vaccination with Ricin Toxin-Immune Complexes
  38. Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
  39. The SeroNet Clinical and Translational Serology Task Force (CTTF) SARS-CoV-2 mucosal immunity methodological considerations and best practices workshop
  40. An ancillary carbohydrate recognition domain on ricin toxin's B subunit is the target of receptor-blocking, neutralizing monoclonal antibodies
  41. Structure of a transmission blocking antibody in complex with Outer surface protein A from the Lyme disease spirochete, Borreliella burgdorferi
  42. Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
  43. Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018TM Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen
  44. Flagellar-based motility accelerates IgA-mediated agglutination of Salmonella Typhimurium at high bacterial cell densities
  45. Structural Elucidation of a Protective B Cell Epitope on Outer Surface Protein C (OspC) of the Lyme Disease Spirochete, Borreliella burgdorferi
  46. mRNA delivery of dimeric human IgA protects mucosal tissues from bacterial infection
  47. An mRNA-Based Platform for the Delivery of Pathogen-Specific IgA into Mucosal Secretions
  48. Serum antibody profiling identifies vaccine-induced correlates of protection against aerosolized ricin toxin in rhesus macaques
  49. High-Throughput Epitope Mapping by Hydrogen Exchange-Mass Spectrometry
  50. Structural Elucidation of a Protective B cell Epitope on Outer Surface Protein C (OspC) of the Lyme disease spirochete,Borreliella burgdorferi
  51. Human B Cell Epitope Map of the Lyme Disease Vaccine Antigen, OspA
  52. Agglutination of Borreliella burgdorferi by Transmission-Blocking OspA Monoclonal Antibodies and Monovalent Fab Fragments
  53. Gut microbiome and breast-feeding: Implications for early immune development
  54. Serological Analysis Identifies Consequential B Cell Epitopes on the Flexible Linker and C-Terminus of Decorin Binding Protein A (DbpA) from Borrelia burgdorferi
  55. Transcytosis of IgA Attenuates Salmonella Invasion in Human Enteroids and Intestinal Organoids
  56. Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
  57. Durable Immunity to Ricin Toxin Elicited by Intranasally Administered Monoclonal Antibody–Based Immune Complexes
  58. Editorial: Mucosal Vaccination: Strategies to Induce and Evaluate Mucosal Immunity
  59. Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies
  60. Single-domain antibodies neutralize ricin toxin intracellularly by blocking access to ribosomal P-stalk proteins
  61. The Flexible Linker of Decorin Binding Protein A from Borrelia burgdorferi is a Target of Antibodies in Lyme disease
  62. Neutralization of Typhoid Toxin by Alpaca-Derived, Single-Domain Antibodies Targeting the PltB and CdtB Subunits
  63. Necroptosis of Lung Epithelial Cells Triggered by Ricin Toxin and Bystander Inflammation
  64. Single-Domain Antibodies for Intracellular Toxin Neutralization
  65. Durable Immunity to Ricin Toxin Elicited by a Thermostable, Lyophilized Subunit Vaccine
  66. Estimating Vaccine Potency Using Antibody-Based Competition Assays
  67. Salmonella Uptake into Gut-Associated Lymphoid Tissues: Implications for Targeted Mucosal Vaccine Design and Delivery
  68. Differential ER stress as a driver of cell fate following ricin toxin exposure
  69. Durable Immunity to Ricin Toxin Elicited by a Thermostable, Lyophilized Subunit Vaccine
  70. The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
  71. The structural basis of Salmonella A2B5 toxin neutralization by antibodies targeting the glycan-receptor binding subunits
  72. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity
  73. Structural Analysis of Toxin-Neutralizing, Single-Domain Antibodies that Bridge Ricin’s A-B Subunit Interface
  74. Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody
  75. Mechanisms of typhoid toxin neutralization by antibodies targeting glycan receptor binding and nuclease subunits
  76. Recombinant Human Secretory IgA Induces Salmonella Typhimurium Agglutination and Limits Bacterial Invasion into Gut-Associated Lymphoid Tissues
  77. Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time
  78. Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis
  79. Mucoricin is a Ricin-Like Toxin that is Critical for the Pathogenesis of Mucormycosis
  80. Sensitization of Airway Epithelial Cells to Toxin-Induced Death by TNF Superfamily Cytokines
  81. Sites of vulnerability on ricin B chain revealed through epitope mapping of toxin-neutralizing monoclonal antibodies
  82. Potency determination of ricin toxin using a monoclonal antibody-based competition assay
  83. Serological Analysis Reveals an Imbalanced IgG Subclass Composition Associated with COVID-19 Disease Severity
  84. Endpoint and epitope-specific antibody responses as correlates of vaccine-mediated protection of mice against ricin toxin
  85. Sites of Vulnerability on Ricin B Chain Revealed through Epitope Mapping of Toxin-Neutralizing Monoclonal Antibodies
  86. Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies
  87. Endpoint and Epitope-specific Antibody Responses as Correlates of Vaccine-mediated Protection of Mice against Ricin Toxin
  88. Passive Immunity to <em>Vibrio cholerae</em> O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk
  89. The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease
  90. A Humanized Monoclonal Antibody Cocktail to Prevent Pulmonary Ricin Intoxication
  91. Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies
  92. Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin
  93. Intracellular Neutralization of Ricin Toxin by Single-domain Antibodies Targeting the Active Site
  94. Mechanisms of Typhoid Toxin Neutralization by Antibodies Targeting Receptor-Binding and Nuclease Subunits
  95. The Structural Basis of Salmonella A <sub>2</sub>B <sub>5</sub> Neutralization by Antibodies Targeting the Glycan-Receptor Binding Subunits
  96. An intranasally administered monoclonal antibody cocktail abrogates ricin toxin-induced pulmonary tissue damage and inflammation
  97. Intracellular Neutralization of Ricin Toxin by Single Domain Antibodies Targeting the Active Site Pocket
  98. Inhibition of Invasive Salmonella by Orally Administered IgA and IgG Monoclonal Antibodies
  99. TNF Family Cytokines Induce Distinct Cell Death Modalities in the A549 Human Lung Epithelial Cell Line when Administered in Combination with Ricin Toxin
  100. Sensitivity of Kupffer cells and liver sinusoidal endothelial cells to ricin toxin and ricin toxin–Ab complexes
  101. Rescue of rhesus macaques from the lethality of aerosolized ricin toxin
  102. A Collection of Single-Domain Antibodies that Crowd Ricin Toxin’s Active Site
  103. TRAIL (CD253) Sensitizes Human Airway Epithelial Cells to Toxin-Induced Cell Death
  104. A Humanized Monoclonal Antibody against the Enzymatic Subunit of Ricin Toxin Rescues Rhesus macaques from the Lethality of Aerosolized Ricin
  105. Biomedical Applications of Lumazine Synthase
  106. Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine
  107. Fine-Specificity Epitope Analysis Identifies Contact Points on Ricin Toxin Recognized by Protective Monoclonal Antibodies
  108. Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity
  109. Fine Specificity Epitope Analysis by HX-MS Identifies Contact Points on Ricin Toxin Recognized by Protective Monoclonal Antibodies
  110. TRAIL (CD253) Sensitizes Human Airway Epithelial Cells to Toxin-Induced Cell Death
  111. Alpha-galactosylceramide (αGalCer) enhances vaccine-induced protection in a model of ricin intoxication
  112. Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination
  113. A Supercluster of Neutralizing Epitopes at the Interface of Ricin’s Enzymatic (RTA) and Binding (RTB) Subunits
  114. High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit Vaccine
  115. High-Resolution Epitope Positioning of a Large Collection of Neutralizing and Nonneutralizing Single-Domain Antibodies on the Enzymatic and Binding Subunits of Ricin Toxin
  116. Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display
  117. Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodies
  118. Spatial location of neutralizing and non-neutralizing B cell epitopes on domain 1 of ricin toxin’s binding subunit
  119. Structural analysis of single domain antibodies bound to a second neutralizing hot spot on ricin toxin's enzymatic subunit
  120. super-resolution
  121. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes
  122. A Novel Zak Knockout Mouse with a Defective Ribotoxic Stress Response
  123. Humanized Monoclonal Antibody That Passively Protects Mice against Systemic and Intranasal Ricin Toxin Challenge
  124. Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit
  125. A Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and Trafficking
  126. Novel Ricin Subunit Antigens With Enhanced Capacity to Elicit Toxin-Neutralizing Antibody Responses in Mice
  127. Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils
  128. Progress and challenges associated with the development of ricin toxin subunit vaccines
  129. Neutralizing Monoclonal Antibodies against Disparate Epitopes on Ricin Toxin’s Enzymatic Subunit Interfere with Intracellular Toxin Transport
  130. Recent advances in the development of vaccines against ricin
  131. Role of Maternal Dietary Peanut Exposure in Development of Food Allergy and Oral Tolerance
  132. Sampling of Candida albicans and Candida tropicalis by Langerin-positive dendritic cells in mouse Peyer’s patches
  133. Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens
  134. Mechanisms of Ricin Toxin Neutralization Revealed through Engineered Homodimeric and Heterodimeric Camelid Antibodies
  135. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide
  136. Phenotypic Analysis of a Population of IgA+ Cells in the Follicle-Associated Epithelium of Mouse Peyer's Patches
  137. Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection
  138. Rapid Effects of a Protective O-Polysaccharide-Specific Monoclonal IgA on Vibrio cholerae Agglutination, Motility, and Surface Morphology
  139. Glassy-State Stabilization of a Dominant Negative Inhibitor Anthrax Vaccine Containing Aluminum Hydroxide and Glycopyranoside Lipid A Adjuvants
  140. Combination of two candidate subunit vaccine antigens elicits protective immunity to ricin and anthrax toxin in mice
  141. Biological Activities of IgA
  142. A tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxin
  143. Oral Interleukin-10 Alleviates Polyposis via Neutralization of Pathogenic T-Regulatory Cells
  144. Crystal Structures of Ricin Toxin's Enzymatic Subunit (RTA) in Complex with Neutralizing and Non-Neutralizing Single-Chain Antibodies
  145. Mice Deficient in Intestinal Epithelium Cytochrome P450 Reductase are Prone to Acute Toxin-induced Mucosal Damage
  146. Differential Neutralizing Activities of a Single Domain Camelid Antibody (VHH) Specific for Ricin Toxin’s Binding Subunit (RTB)
  147. Antibody-Mediated Inhibition of Ricin Toxin Retrograde Transport
  148. A Population of Langerin-Positive Dendritic Cells in Murine Peyer's Patches Involved in Sampling β-Glucan Microparticles
  149. Localization of non-linear neutralizing B cell epitopes on ricin toxin's enzymatic subunit (RTA)
  150. Chimeric Plantibody Passively Protects Mice against Aerosolized Ricin Challenge
  151. Stepwise Engineering of Heterodimeric Single Domain Camelid VHH Antibodies That Passively Protect Mice from Ricin Toxin
  152. Three-Dimensional Reconstruction of Murine Peyer's Patches from Immunostained Cryosections
  153. Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine
  154. Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization
  155. Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro
  156. Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments
  157. LT-IIb(T13I), a Non-Toxic Type II Heat-Labile Enterotoxin, Augments the Capacity of a Ricin Toxin Subunit Vaccine to Evoke Neutralizing Antibodies and Protective Immunity
  158. Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen
  159. Comparative Efficacy of Two Leading Candidate Ricin Toxin A Subunit Vaccines in Mice
  160. High‐Throughput, Cell‐Based Screens to Identify Small‐Molecule Inhibitors of Ricin Toxin and Related Category B Ribosome Inactivating Proteins (RIPs)
  161. Exposure of Salmonella enterica Serovar Typhimurium to a Protective Monoclonal IgA Triggers Exopolysaccharide Production via a Diguanylate Cyclase-Dependent Pathway
  162. Identification of Small Molecules That Suppress Ricin-Induced Stress-Activated Signaling Pathways
  163. Resolution of two overlapping neutralizing B cell epitopes within a solvent exposed, immunodominant α-helix in ricin toxin's enzymatic subunit
  164. FRUIT, a Scar-Free System for Targeted Chromosomal Mutagenesis, Epitope Tagging, and Promoter Replacement in Escherichia coli and Salmonella enterica
  165. Sub-Domains of Ricin’s B Subunit as Targets of Toxin Neutralizing and Non-Neutralizing Monoclonal Antibodies
  166. Association of a Protective Monoclonal IgA with the O Antigen of Salmonella enterica Serovar Typhimurium Impacts Type 3 Secretion and Outer Membrane Integrity
  167. Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit
  168. Rediscovering IgA
  169. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut
  170. Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB)
  171. Role of the Mannose Receptor (CD206) in Innate Immunity to Ricin Toxin
  172. Transient Suppression of Shigella flexneri Type 3 Secretion by a Protective O-Antigen-Specific Monoclonal IgA
  173. Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA
  174. Small-Molecule Inhibitors of Ricin and Shiga Toxins
  175. Mucosal Vaccines for Biodefense
  176. Immunity to Ricin: Fundamental Insights into Toxin–Antibody Interactions
  177. Folding domains within the ricin toxin A subunit as targets of protective antibodies
  178. Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screen
  179. Identification of new classes of ricin toxin inhibitors by virtual screening
  180. Recognition of secretory IgA by DC-SIGN: Implications for immune surveillance in the intestine
  181. Secretory IgA: Arresting Microbial Pathogens at Epithelial Borders
  182. A Monoclonal Immunoglobulin G Antibody Directed against an Immunodominant Linear Epitope on the Ricin A Chain Confers Systemic and Mucosal Immunity to Ricin
  183. Neutralizing Monoclonal Antibodies Directed against Defined Linear Epitopes on Domain 4 of Anthrax Protective Antigen
  184. RicinA Type II Ribosome-Inactivating Protein
  185. Inhibition of Salmonella enterica Serovar Typhimurium Motility and Entry into Epithelial Cells by a Protective Antilipopolysaccharide Monoclonal Immunoglobulin A Antibody
  186. Evidence for Widespread Epithelial Damage and Coincident Production of Monocyte Chemotactic Protein 1 in a Murine Model of Intestinal Ricin Intoxication
  187. IgA and Antigen Sampling
  188. Characterization of a Novel High-Affinity Monoclonal Immunoglobulin G Antibody against the Ricin B Subunit
  189. Immunoglobulin A Antibodies against Ricin A and B Subunits Protect Epithelial Cells from Ricin Intoxication
  190. Ricin induces IL-8 secretion from human monocyte/macrophages by activating the p38 MAP kinase pathway
  191. Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin
  192. Analysis of Adhesion Molecules Involved in Leukocyte Homing into the Basolateral Pockets of Mouse Peyer's Patch M Cells
  193. The Viral σ1 Protein and Glycoconjugates Containing α2-3-Linked Sialic Acid Are Involved in Type 1 Reovirus Adherence to M Cell Apical Surfaces
  194. Collaboration of epithelial cells with organized mucosal lymphoid tissues
  195. Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies
  196. Immunization of mice with peptomers covalently coupled to aluminum oxide nanoparticles
  197. The composition and function of M cell apical membranes: Implications for microbial pathogenesis
  198. The
  199. Host recognition by the VirA, VirG two-component regulatory proteins of Agrobacterium tumefaciens
  200. The Intestinal Epithelium: The Interface Between Host and Pathogen